Researchers compared hepatitis C virus point-of-care RNA viral load testing with laboratory-based testing to determine the effects on treatment uptake and turnaround times.
Studies show that mortality, morbidity, and hepatic decompensation risks increase with coinfection of HIV and HCV, indicating that adequate and efficient treatment must be provided for both viruses.
Liver disease and cirrhosis now outpace diabetes and stroke as the leading cause of mortality in people aged 25 to 54 years. New survey results shows shortfalls in adoption of national treatment guidelines for liver disease and cirrhosis.
Researchers evaluated patients with HIV infection who received the HepB-CpG vaccine, a hepatitis B surface antigen vaccine adjuvanted with a toll-like receptor 9 agonist.
Adults at risk of hepatitis A and hepatitis B have multi-dose vaccinations available, but complete and timely vaccination adherence rates are low. What can be done to encourage more vaccine adherence?
In this study, researchers assessed the nationwide rate of testing and treatment initiations for hepatitis C virus infection in the United States following the onset of the COVID-19 pandemic through the end of 2020.
People with hepatitis C are at an increased risk for several autoimmune disorders. Researchers sought to discover a link between the virus and hypothyroidism.